MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2017 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBALSPB |
Anteile |
51.7 M |
Marktkapitalisierung |
$ 370 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Biogen
BIIB
|
$ 254.56 | 2.26 % | $ 37.3 B | Nasdaq Global Select Market,SPB | USA |
 |
BioLineRx Ltd.
BLRX
|
$ 1.87 | -2.09 % | $ 4.61 B | Nasdaq Capital Market |  Israel |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 1.67 | 3.73 % | $ 2.75 M | NYSE American | Israel |
 |
Forte Biosciences
FBRX
|
$ 76.99 | 0.03 % | $ 997 M | Nasdaq Capital Market | USA |
 |
Celldex Therapeutics
CLDX
|
$ 29.92 | 0.71 % | $ 1.99 B | Nasdaq Global Select Market | USA |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market |  Canada |
 |
AIM ImmunoTech
AIM
|
$ 0.16 | 1.12 % | $ 259 K | NYSE American | USA |
 |
Ascendis Pharma A/S
ASND
|
$ 257.48 | 2.92 % | $ 15.6 B | Nasdaq Global Select Market |  Danmark |
 |
ANI Pharmaceuticals
ANIP
|
$ 71.6 | -0.94 % | $ 1.44 B | Nasdaq Global Market,SPB | USA |
 |
Actinium Pharmaceuticals
ATNM
|
$ 1.42 | 1.43 % | $ 44.3 M | NYSE American | USA |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.37 | -3.53 % | $ 365 M | Nasdaq Global Select Market |  Britain |
 |
BridgeBio Pharma
BBIO
|
$ 77.85 | 5.16 % | $ 14.9 B | Nasdaq Global Select Market,SPB | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
$ 8.26 | -3.68 % | $ 1.73 B | Nasdaq Global Select Market | USA |
 |
Bicycle Therapeutics plc
BCYC
|
$ 3.72 | 1.36 % | $ 258 M | Nasdaq Global Select Market | Britain |
 |
Coherus BioSciences
CHRS
|
$ 0.85 | 5.95 % | $ 99.6 M | Nasdaq Global Market | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 34.23 | 6.95 % | $ 4.36 B | Nasdaq Global Select Market,SPB | USA |
 |
Cellectis S.A.
CLLS
|
$ 1.14 | 4.59 % | $ 114 M | Nasdaq Global Market |  France |
 |
BeyondSpring
BYSI
|
$ 0.68 | 9.47 % | $ 28 M | Nasdaq Capital Market | USA |
 |
Alkermes plc
ALKS
|
$ 45.87 | 0.38 % | $ 7.55 B | Nasdaq Global Select Market |  Irlanda |
 |
Altimmune
ALT
|
$ 2.1 | 2.94 % | $ 185 M | Nasdaq Global Market | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
$ 10.84 | 13.63 % | $ 297 M | Nasdaq Global Market,SPB | Israel |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 61.68 | 3.61 % | $ 8.25 B | Nasdaq Global Select Market,SPB | USA |
 |
Atara Biotherapeutics
ATRA
|
$ 8.4 | 2.44 % | $ 105 M | Nasdaq Global Select Market,SPB | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
$ 17.11 | 3.35 % | $ 2.3 B | Nasdaq Global Market | Canada |
 |
Cullinan Management
CGEM
|
$ 12.53 | -20.44 % | $ 755 M | Nasdaq Global Select Market | USA |
 |
BioNTech SE
BNTX
|
$ 90.3 | 3.89 % | $ 21.8 B | Nasdaq Global Select Market |  Germany |
 |
Collegium Pharmaceutical
COLL
|
$ 23.66 | -0.32 % | $ 749 M | Nasdaq Global Select Market | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
$ 3.59 | -7.24 % | $ 47.8 M | Nasdaq Global Market | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
$ 1.4 | -4.11 % | $ 64 M | Nasdaq Capital Market | Israel |
 |
AnaptysBio
ANAB
|
$ 47.52 | -0.44 % | $ 1.38 B | Nasdaq Global Select Market,SPB | USA |
 |
Assembly Biosciences
ASMB
|
$ 19.81 | -0.55 % | $ 222 M | Nasdaq Global Select Market,SPB | USA |
 |
Adagene
ADAG
|
$ 2.43 | 3.4 % | $ 143 M | Nasdaq Global Market |  China |
 |
Benitec Biopharma
BNTC
|
$ 9.07 | 7.98 % | $ 422 M | Nasdaq Capital Market | USA |
 |
Denali Therapeutics
DNLI
|
$ 20.93 | 7.61 % | $ 3.61 B | Nasdaq Global Select Market,SPB | USA |
 |
Amarin Corporation plc
AMRN
|
$ 12.29 | 1.99 % | $ 5.1 B | Nasdaq Global Market | Irlanda |
 |
Editas Medicine
EDIT
|
$ 2.72 | 4.62 % | $ 241 M | Nasdaq Global Select Market,SPB | USA |
 |
Agios Pharmaceuticals
AGIO
|
$ 31.42 | 0.71 % | $ 1.82 B | Nasdaq Global Select Market,SPB | USA |
 |
Cue Biopharma
CUE
|
$ 19.81 | -5.03 % | $ 1.88 B | Nasdaq Capital Market,SPB | USA |
 |
Equillium
EQ
|
$ 1.39 | -1.42 % | $ 79.7 M | Nasdaq Global Market | USA |
 |
Black Diamond Therapeutics
BDTX
|
$ 1.9 | 4.97 % | $ 108 M | Nasdaq Global Select Market,SPB | USA |
 |
Abeona Therapeutics
ABEO
|
$ 4.22 | -0.82 % | $ 223 M | Nasdaq Capital Market | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 21.49 | 4.47 % | $ 3.62 B | Nasdaq Global Select Market,SPB | USA |
 |
Atossa Therapeutics
ATOS
|
$ 2.12 | -9.01 % | $ 18.3 M | Nasdaq Capital Market | USA |
 |
Cleveland BioLabs, Inc.
CBLI
|
- | -7.31 % | $ 49 M | Nasdaq Capital Market | USA |
 |
AC Immune SA
ACIU
|
$ 2.25 | 7.66 % | $ 227 M | Nasdaq Global Market |  Schweiz |
 |
Five Prime Therapeutics, Inc.
FPRX
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
ADC Therapeutics SA
ADCT
|
$ 1.72 | 10.65 % | $ 219 M | NYSE | Schweiz |
 |
Harmony Biosciences Holdings
HRMY
|
$ 34.48 | -6.87 % | $ 1.98 B | Nasdaq Global Select Market | USA |
 |
Ardelyx
ARDX
|
$ 3.29 | 8.42 % | $ 793 M | Nasdaq Global Market | USA |
 |
Akebia Therapeutics
AKBA
|
$ 0.69 | -4.49 % | $ 177 M | Nasdaq Global Market | USA |